Recent Emerging Trend in Stem Cell Therapy Risk Factors.
MSC
Stem cells
cell therapy
multipotent
pluripotent
risk factors
Journal
Current stem cell research & therapy
ISSN: 2212-3946
Titre abrégé: Curr Stem Cell Res Ther
Pays: United Arab Emirates
ID NLM: 101272517
Informations de publication
Date de publication:
2023
2023
Historique:
received:
17
07
2022
revised:
15
10
2022
accepted:
08
11
2022
medline:
14
7
2023
pubmed:
26
12
2022
entrez:
25
12
2022
Statut:
ppublish
Résumé
Different types of stem cells have remarkable characteristics such as high proliferation rate, multi/pluripotency, self-renewal, and broad differentiation that can effectively treat diseases, cancers, and damage. Despite abundant therapeutic applications of stem cells in medical science, numerous risks threaten stem cell transplantation. Tumor development, immune response, cellular senescence, dosage effects, and administration timing are critical risks that should be considered in stem cell therapy. Hence, an investigation of possible risks is required before utilizing stem cell-based medicinal products in the clinical phase and human trials. This review aims to survey the literature and perspectives on the advantages and risks associated with pluripotent and multipotent stem cells.
Identifiants
pubmed: 36567298
pii: CSCR-EPUB-128410
doi: 10.2174/1574888X18666221223104859
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1076-1089Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.